Showing results (121-130 of 182) with videos related to
Sort By:
Pageof 19
ACS Medicinal Chemistry Letters|November 21, 2017
Discovery of Thiophene[3,2-<i>d</i>]pyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the Tolerant Region I of NNIBPDongwei Kang, Xiao Ding, Gaochan Wu, et al.European Journal of Medicinal Chemistry|April 11, 2018
Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virusYe Tian, Zhaoqiang Liu, Jinghan Liu, et al.Chemical Biology & Drug Design|November 2, 2018
Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors by exploring the structure-activity relationship of solvent-exposed regions IDongwei Kang, Zhao Wang, Meng Chen, et al.Journal of Medicinal Chemistry|August 20, 2016
Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance ProfilesDongwei Kang, Zengjun Fang, Zhenyu Li, et al.Bioorganic & Medicinal Chemistry|February 26, 2025
Optimizing biofilm inhibitors: Balancing activity and toxicity in 2N-aminated 5-aryl-2-aminoimidazolesLynn Maetens, Banibrata Maiti, Freya Cools, et al.Biochemical Pharmacology|July 25, 2024
Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cellsKristof De Vos, Adamantios Mavrogiannis, Justina Clarinda Wolters, et al.Virology|May 15, 2007
Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanionsClaire Bertaux, Dirk Daelemans, Laurent Meertens, et al.The Journal of Clinical Investigation|October 20, 2007
Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voidingThomas Gevaert, Joris Vriens, Andrei Segal, et al.Emerging Microbes & Infections|November 18, 2021
Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in miceJi Ma, Robbert Boudewijns, Lorena Sanchez-Felipe, et al.Chemical Biology & Drug Design|August 7, 2018
Design, synthesis, and antiviral evaluation of novel hydrazone-substituted thiophene[3,2-d]pyrimidine derivatives as potent human immunodeficiency virus-1 inhibitorsZhao Wang, Dongwei Kang, Meng Chen, et al.Pageof 19